Passage Bio, Inc.
PASG
$0.3117
-$0.0145-4.45%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 34.20% | -20.94% | 4.31% | 0.28% | 38.19% |
| Total Depreciation and Amortization | -5.27% | -4.77% | -1.12% | -0.12% | -15.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 57.74% | 235.89% | 49.35% | 59.42% | -90.85% |
| Change in Net Operating Assets | -203.47% | 1,481.12% | 108.12% | 2.61% | -373.18% |
| Cash from Operations | -13.39% | 43.31% | 30.60% | 3.01% | -1.84% |
| Capital Expenditure | 30.00% | -- | -- | -- | -225.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -8.65% | 1,330.25% | -95.85% | 231.68% | -66.10% |
| Cash from Investing | -8.62% | 1,328.34% | -95.85% | 232.25% | -66.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -99.03% | 18,904.35% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -99.03% | 18,904.35% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.79% | 162.67% | -179.68% | 226.91% | -461.01% |